COO: Earnings beat expectations with record cash flow, strong fertility, and renewed growth focus
Q3 results exceeded expectations with record free cash flow and a major tax benefit. CooperVision was impacted by U.S. inventory reductions, but underlying demand is solid, while CooperSurgical saw continued fertility growth. Strategic review ended with no sale, and focus shifts to organic growth a…